Saw Palmetto for the Prostate: What the Evidence Actually Shows
The most popular prostate supplement in the world, and the one with the most uncomfortable trial data. Both sides of the argument, fairly.
If you have looked at a prostate supplement, you have looked at saw palmetto. It is in almost every formula in the category, including our top-rated NuProstate. It is also the ingredient with the widest gap between how confidently it is marketed and what the best trials found.
What it is and how it is meant to work
Serenoa repens is a dwarf palm native to the south-eastern United States. The supplement is made from its berries, usually as a lipidosterolic extract — a fat-soluble concentrate standardised for fatty acids and phytosterols.
The proposed mechanism is genuinely plausible. Saw palmetto appears to inhibit 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone. DHT is the hormone that drives prostate growth — it is the same enzyme that prescription drugs like finasteride block, far more powerfully. Saw palmetto is also thought to have anti-inflammatory effects and to relax smooth muscle in the bladder neck.
The case against: the big trials were negative
This is the part most articles skip, so here it is plainly.
The STEP trial, published in the New England Journal of Medicine in 2006, randomised men with moderate-to-severe BPH to 320 mg of saw palmetto extract a day or placebo for one year. There was no significant difference in symptom scores or peak flow rate.
CAMUS, published in JAMA in 2011, went further. It escalated the dose to 640 mg and then 960 mg a day — two and three times the standard dose — over 72 weeks. Still no significant benefit over placebo.
A Cochrane review pooling the available trials reached the same conclusion: saw palmetto was no more effective than placebo for urinary symptom scores or flow rate.
The case for: extracts are not interchangeable
The counter-argument is real and worth stating. “Saw palmetto” is not one substance. The extraction method — hexane, ethanol, supercritical CO2 — produces materially different chemistry, and the trials above used specific preparations.
Trials of a particular hexanic extract used widely in Europe have reported modest improvements in symptoms and nocturia, and reviews restricted to that preparation are more favourable than reviews that lump everything together. Whether that is a genuine extract-specific effect or a difference in study design and sponsorship is actively argued.
The second point in its favour is that the placebo response in BPH trials is unusually large — often a 4 to 6 point improvement on the IPSS scale. That does not mean saw palmetto works. It does mean that men who feel better on it are not imagining the improvement; they are just probably not getting it from the palm berry.
The honest summary
- Plausible mechanism, decades of use, excellent safety record.
- The two largest, best-designed trials found no benefit over placebo.
- Extract type may matter; the evidence for that is suggestive, not settled.
- 320 mg a day is the dose to look for — anything less is below what was even tested.
- Low risk to try, low expectation warranted.
Safety, and one thing to tell your doctor
Saw palmetto is well tolerated. The most common complaints are mild digestive upset and headache, at rates close to placebo. It may have a mild antiplatelet effect, so mention it if you take anticoagulants or have surgery scheduled.
The important one: saw palmetto can lower PSA readings. PSA is used to screen for prostate cancer, and a falsely reassuring number is a genuine harm. Always tell the clinician ordering the test that you are taking it.
So should you take it?
If your symptoms are mild, you have been assessed, and you understand the odds, trying it for eight to twelve weeks costs little and risks less. Score yourself on the IPSS before and after so you are judging against a number rather than a memory. If you want the ingredient with the more consistent trial record, read our guide to beta-sitosterol instead.
Sources
- Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. New England Journal of Medicine. 2006;354(6):557–566.
- Barry MJ, Meleth S, Lee JY, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms. JAMA. 2011;306(12):1344–1351.
- Tacklind J, MacDonald R, Rutks I, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. 2012.
Our 2026 pick is NuProstate, the one formula in the category that publishes its saw palmetto at the clinically studied 320 mg. Read the full review, including where we disagree with the seller, or see the full ranking.
Medical disclaimer: this article is educational only and is not medical advice. Dietary supplement statements have not been evaluated by the FDA and these products are not intended to diagnose, treat, cure or prevent any disease. Urinary symptoms in men over 50 should be assessed by a doctor, because benign prostatic hyperplasia, prostate cancer and urinary infection can present in exactly the same way. Never delay a medical assessment in order to try a supplement first.